The Current Ratio as of December 2025 (TTM) for Jiangsu Recbio Technology Co., Ltd. (2179.HK) is 0.32

According to Jiangsu Recbio Technology Co., Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 0.32. This represents a change of -73.42% compared to the average of 1.20 of the last 4 quarters.

Jiangsu Recbio Technology Co., Ltd. (2179.HK) Historical Current Ratio (quarterly & annually)

How has 2179.HK Current Ratio performed in the past?

The mean historical Current Ratio of Jiangsu Recbio Technology Co., Ltd. over the last ten years is 7.79. The current 0.32 Current Ratio has changed 310.30% with respect to the historical average. Over the past ten years (40 quarters), 2179.HK's Current Ratio was at its highest in in the December 2020 quarter at 12.34. The Current Ratio was at its lowest in in the June 2020 quarter at 0.

Jiangsu Recbio Technology Co., Ltd. (2179.HK) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Jiangsu Recbio Technology Co., Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Jiangsu Recbio Technology Co., Ltd. (2179.HK) Average Current Ratio

How has 2179.HK Current Ratio performed in the past?

The current Current Ratio of Jiangsu Recbio Technology Co., Ltd. (2179.HK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Jiangsu Recbio Technology Co., Ltd. (2179.HK) Current Ratio vs. Peers

How is 2179.HK’s Current Ratio compared to its peers?

Jiangsu Recbio Technology Co., Ltd.’s Current Ratio is greater than Clover Biopharmaceuticals, Ltd. (0.26), less than ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (3.33), less than Antengene Corporation Limited (4.47), less than Cutia Therapeutics (3.16), less than HighTide Therapeutics Inc (3.44), less than AIM Vaccine Co., Ltd. (0.73), less than Hua Medicine (Shanghai) Ltd. (7.79), less than Zhaoke Ophthalmology Limited (4.40), less than SinoMab BioScience Limited (0.87), less than Mabpharm Limited (1.07),

Build a custom stock screener for Jiangsu Recbio Technology Co., Ltd. (2179.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Jiangsu Recbio Technology Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Jiangsu Recbio Technology Co., Ltd. (2179.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Jiangsu Recbio Technology Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.